Manufacturer record
J.M. Laboratories: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
18 batches manufactured by J.M. Laboratories (Himachal Pradesh) were declared Not of Standard Quality between February 2021 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: GT35462A, Olmesartan Medoxomil, Hydrochlorothiazide (exp Jun 2028). DTL, Jaipur (state lab) found it not of standard quality: The sample does not conforms to the claim with respect to Assay of Olmesartan Medoxomil. Listed in the September 2026 alert.
Records by type
18 records linked to J.M. Laboratories in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Olmesartan Medoxomil, Hydrochlorothiazide | Batch GT35462AMfg Jul 2026 · Exp Jun 2028 | The sample does not conforms to the claim with respect to Assay of Olmesartan Medoxomil.Assay | DTL, JaipurState lab | Sep 2026 |
| Azithromycin & Lactic Acid Bacillus Tablets | Batch GT30389JMfg Dec 2025 · Exp Nov 2027 | The sample does not conform to claim as per Schedule V of Drug and Cosmetics Act and Rules 1945 with respect to Assay of Lactic Acid Bacillus.Assay | CDL, KolkataCDSCO lab | Aug 2026 |
| Clopidogrel & Aspirin Tablets | Batch GT31923CMfg Feb 2026 · Exp Jan 2028 | Free salicylic Acid (12.01%) and Content of Aspirin (77.13%)Other | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Cefuroxime Axetil & Potassium Clavulanate Tablets I.P. | Batch CXCA25014EMfg Aug 2025 · Exp Jan 2027 | The sample does not conform to I.P. with respect to the tests of Dissolution and Assay of Cefuroxime and Clavulanic Acid.Assay | CDL, KolkataCDSCO lab | Jul 2026 |
| Pioglitazone Hydrochloride Tablets IP | Batch GT27476AMfg Aug 2025 · Exp Jul 2027 | Test for DissolutionDissolution | DTL, Bengaluru, KarnatakaState lab | Mar 2026 |
| (Paracetamol, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Tablets) | Batch GT27292CMfg Aug 2025 · Exp Jul 2027 | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab | Mar 2026 |
| Aceclofenac & Paracetamol Tablets | Batch GT18022BMfg Feb 2025 · Exp Jan 2027 | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab | Feb 2026 |
| Calcium Carbonate & Vitamin D3 Tablets IP | Batch GT17894CMfg Feb 2025 · Exp Jan 2027 | The sample does not conform to claim as per IP 2022 in respect to the Test of Uniformity of content of Vitamin D3Uniformity of weight/content | RDTL, ChandigarhCDSCO lab | Jan 2026 |
| Amoxycillin & Potassium Clavulanate Tablets IP(Amoxheal ? 625) | Batch ACAA24149CMfg Jan 2025 · Exp Jun 2026 | The sample does not conform to standard quality in respect of the test for Dissolution & Assay of Amoxycillin performed.Assay | SDTL, Govt. of Tripura, Agartala. State- TripuraState lab | Dec 2025 |
| Aceclofenac & Paracetamol Tablets | Batch GT16375AMfg Nov 2024 · Exp Oct 2026 | It fails the test Dissolution and Assay as per IP.Assay | RDTL ErnakulamState lab | Nov 2025 |
| Calcium Carbonate & Vitamin D3 Tablets I.P (DPCAL-500) | Batch GT17894CMfg Feb 2025 · Exp Jan 2027 | Test for Dissolution for Calcium and Assay for Vitamin D3Assay | DTL, Bengaluru, KarnatakaState lab | Oct 2025 |
| Tablets, Betahistine Tablets I.P. | Batch GT17056AMfg Dec 2024 · Exp Nov 2026 | Description of TabletsDescription | Drugs Control Laboratory, TelanganaState lab | Jul 2025 |
| Amoxycillin and Potassium Clavulanate Oral Suspension RIGHTCLAV 228.5 Dry Syrup | Batch ACAG24001EMfg Apr 2024 · Exp Sep 2025 | Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate oral suspension with respect to pH and the content of Clavulanic Acid in Potassium Clavulanate dilutedpH | Drugs Testing Laboratory, Madurai-19State lab | May 2025 |
| Phytorab-DSR Capsules | Batch GC 41481Mfg Jun 2023 · Exp May 2025 | The content of rabeprazole sodium in the sample is less (i.e. 55.00% of the labelled amount) than the permissible limitsLabelling | CDTL MumbaiCDSCO lab | Apr 2025 |
| Cefixime & Ofloxacin Tablets (CEPHAFLU- 400) | Batch CT5853AMfg Mar 2024 · Exp Feb 2026 | Assay of CefiximeAssay | CDL KolkataCDSCO lab | Jan 2025 |
| Torsemide Tablets IP (Torverge-10 Tablets) | Batch GT7137AMfg Mar 2023 · Exp Feb 2025 | Assay of Torsemide (86.85%)Assay | RDTL ChandigarhState lab | Oct 2024 |
| Torsemide Tablets IP 10 mg (Torverge- 10 Tablets) | Batch GT7137AMfg Mar 2023 · Exp Feb 2025 | Assay of TorsemideAssay | RDTL ChandigarhCDSCO lab | Sep 2024 |
| Cefpodoxime Proxetil Dispersible Tablets (BROTOCEF-100 DT TABLETS) | Batch CT1904EMfg Dec 2019 · Exp Nov 2021 | AssayAssay | RDTL ChandigarhCDSCO lab | Feb 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.